Have you checked out our newsletter?
Stay ahead with expert insights, strategic tips, and industry trends—all designed to boost your brand's med comm initiatives.
"*" indicates required fields
Get fresh insights and candid perspectives on timely issues impacting the pharmaceutical industry from our blog.
The Latest News
132 Speakers. Three Leadership Changes. No Compromise on Speaker Readiness: A Case Study
Business throws a lot of curveballs. Deadlines tighten. Priorities shift. And sometimes, leadership changes overnight. When you’re navigating that kind of disruption, having a partner who already knows your business can make all the difference. There’s no time to start from scratch or get up to speed on what needs
AMA Calls Obesity a Disease
The American Medical Association has always been an influential player in the medical field, but as of June 19, it took its efforts to a new level. Concern over soaring obesity rates in the United States has skyrocketed as more and more Americans have become overweight. Numerous efforts to address
Protected: Industry Happenings – October 2026
There is no excerpt because this is a protected post.
Industry Insights – August 2026
Stay in tune with the growing changes in drug access and regulatory transparency, including rising insurance denials for brand-name medications and FDA updates around rejection letters and advisory committees. Read on for a closer look at developments shaping the biopharma industry. Source: PharmaVoice Insurance denials for brand-name prescription drugs have
Is Your Congress Strategy Driving Growth or Draining Your Budget?
Before your team commits another dollar to an association congress meeting, ask yourself: Will this meeting move your brand forward or simply add another expense?¹ The challenge is not whether you are showing up; it is whether you are showing up in the right events. How well do you know the